DP
Director, Sales & Marketing
Get the full picture
Sign in to uncover key details.
FORUS Therapeutics
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
200 North Service Rd W Suite 129, Oakvil...Website
www.forustherapeutics.comRevenue
<$5 MillionIndustry
About FORUS Therapeutics
FORUS Therapeutics is a Canadian biopharmaceutical company focused on developing innovative medicines for hematologic malignancies and various cancers. The company aims to provide differentiated treatment options, including their recently approved product, BESREMI, for Polycythemia Vera. Their target clients include healthcare professionals and patients affected by these conditions. With a strong leadership team and a commitment to advancing cancer therapies, FORUS is positioned to make significant contributions to the field of oncology.Explore more
FORUS Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to FORUS Therapeutics
Compare insights from companies similar to FORUS Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
FORUS Therapeutics Tech Stack
A closer look at the technologies used by FORUS Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding FORUS Therapeutics
Sign Up For FreeTo access detailed company insights
FORUS Therapeutics is a Canadian biopharmaceutical company focused on developing innovative medicines for hematologic malignancies and various cancers. The company aims to provide differentiated treatment options, including their recently approved product, BESREMI, for Polycythemia Vera. Their target clients include healthcare professionals and pat... Read More
